High-Risk Needlestick from an HBeAg-Positive Patient: Deciding on Post-Exposure Prophylaxis Without a Rapid Titre
At 21:40 a 22-year-old nursing intern in her third week of ward duty is recapping a needle after an arterial blood gas draw from a 47-year-old man in the intensive care unit. The needle pierces the tip of her left index finger and the wound bleeds freely; she is wearing a single pair of gloves. The patient's records show HBsAg positive, HBeAg positive, HIV negative on a fourth-generation assay and anti-HCV negative. The intern completed a three-dose hepatitis B vaccination course three years ago but has never had her anti-HBs titre checked. She reports the injury to the technician on duty, who washes the wound with running water and soap. The medical officer authorised to sign post-exposure prophylaxis orders is off-site and will return in about four hours. The pharmacy holds hepatitis B immunoglobulin and a starter pack of antiretroviral drugs, but there is no rapid anti-HBs test on site; the send-out ELISA takes 48 hours.
1. Assess the risk of transmission and state which infections require prophylaxis here.
Read the worked answer
Hepatitis B is the real hazard. Risk factors that raise it: a hollow-bore needle contaminated with blood, a wound that bleeds (i.e., a penetrating, non-superficial injury), and a source who is HBsAg positive and HBeAg positive - a marker of high viral replication and the single strongest predictor of transmission (risk of transmission from such a source to an unvaccinated person can exceed 30%). The intern's protection is unproven because her anti-HBs titre was never measured after vaccination; roughly 5–10% of healthy adults do not respond adequately to a full course.
HIV: the source is HIV negative on a fourth-generation assay, so no antiretroviral prophylaxis is indicated. Starting a starter pack 'just in case' would expose her to unnecessary toxicity and is not justified unless the source is re-tested and found positive.
Hepatitis C: the source is anti-HCV negative, so no prophylaxis exists or is needed. HCV has no vaccine and no recommended post-exposure prophylaxis; management is baseline and follow-up testing only.
So the decisions are: hepatitis B immunoglobulin plus a vaccine dose now; HIV and HCV baseline sampling and follow-up, no prophylaxis.
2. What should be done immediately, and what is the correct hepatitis B prophylaxis regimen given that the anti-HBs result will take 48 hours?
Read the worked answer
Wound care: encourage bleeding, wash thoroughly with soap and running water, then irrigate; do not squeeze or milk the wound, and do not apply caustic agents, bleach or alcohol.
Do not wait for the anti-HBs result. Guidelines are explicit that when the vaccinated person's response status is unknown, the exposed person is managed as a non-responder, and immunoglobulin is most effective within 24 hours of exposure (efficacy falls sharply thereafter). The 48-hour ELISA turnaround would therefore consume the window in which HBIG works best.
Regimen: hepatitis B immunoglobulin 0.06 mL/kg intramuscularly as a single dose, given together with a dose of hepatitis B vaccine (a booster in an already-vaccinated person), ideally at a different site. Send the anti-HBs sample anyway - if the titre returns at or above 10 mIU/mL, protection is confirmed and the vaccine dose was harmless; if below 10 mIU/mL, complete the vaccine schedule.
Baseline and follow-up: baseline bloods for HBsAg, anti-HBs, anti-HBc, anti-HCV and HIV; repeat HBsAg and anti-HCV at about 3 and 6 months; counsel on symptoms of acute hepatitis. The antiretroviral starter pack should not be dispensed for this exposure.
3. The medical officer is four hours away. What does that delay reveal about the system, and what should the technician and nurse manager do about it?
Read the worked answer
The delay is a governance failure, not an individual one. A time-critical intervention that must begin within hours cannot depend on the physical presence of a single authoriser. Four hours is long enough to lose most of the benefit of immunoglobulin, and the intern may finish her shift and leave without any prophylaxis being started.
Actions the technician and nurse manager should take: • Activate a standing order / nurse-initiated protocol for post-exposure prophylaxis, with defined criteria and a named on-call authoriser reachable by phone, so the first dose can be given without waiting for a signature. • Keep a sealed PEP kit (HBIG, vaccine, antiretroviral starter pack, baseline sample tubes, algorithm card) in the emergency department, with a documented stock check. • Report the incident to infection control and the hospital's sharps-injury register the same night; the incident number is what triggers follow-up serology. • Fix the root cause: recapping is the single most preventable mechanism of needlestick injury. The unit needs point-of-use sharps containers within arm's reach and a no-recapping rule, plus a review of whether the arterial line was even being managed with a safety-engineered device.